Health Care: Drugs

OncoMed Pharmaceuticals Inc (OMED: NASDAQ)

$25.89 n/a | n/a%
03/27/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 25.89
52 Week High 34.75
52 Week Low 16.57
Avg. Daily Vol. (Mil) 0.16
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 775.20
Shares Out (Mil) 29.94
Float (Mil) 13.21
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.20
Current Ratio 6.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 19.60
Price/Book 10.15
Price/Cash Flow -16.00
Per Share Data
Earnings -1.69
Sales 1.32
Book Value 2.55
Cash Flow -1.62
Business Summary
OncoMed Pharmaceuticals Inc is a clinical development-stage biopharmaceutical company focused on discovering and developing novel protein therapeutics targeting cancer stem cells, or CSCs.
General Information
800 Chesapeake Drive
Redwood City, CA 94063
www.oncomed.com
Industry : Drugs
Sector: Health Care
Employees: 108
CEO: Paul J. Hastings
Short Interest
Current Month (Mil) 1.83
Previous Month (Mil) 1.92
Short Interest Ratio (Days) 13.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -20.20
Return on Investments -65.50
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with OMED

Latest OMED Headlines from TheStreet

More Financial News for OMED

Press Releases for OMED

See All Press Releases

Partner Headlines for OMED

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter